NEUROTHERAPIA INC

$1,213,723

from Department of Health and Human Services · National Institutes of Health

PRECLINICAL TOXICOLOGY IN ANIMALS TO PROVE THE SAFETY OF A NOVEL ALZHEIMER'S DISEASE TREATMENT - PROJECT SUMMARY/ABSTRACT TREATMENT WITH MONOCLONAL ANTIBODY THERAPEUTICS, SUCH AS ADUCANUMAB AND, MOST RECENTLY DONANEMAB, CAN SIGNIFICANTLY SLOW THE PROGRESSION OF THE DISEASE IN THE EARLY STAGES OF ALZHEIMER’S DISEASE (AD). HOWEVER, THE USE OF ANTI-AΒ ANTIBODIES HAS BEEN ASSOCIATED WITH TREATMENT-...
Description as recorded in the federal award record (cut at 400 characters).

Award ID: R44AG102269
Award type: PROJECT GRANT (B)
First obligated: Sep 8, 2026
Period starts: Sep 8, 2026
Place of performance: Cuyahoga County, Ohio 44106
Assistance listing: 93.866 AGING RESEARCH
Amount means: Federal obligation for this grant, as of our last read Oct 13, 2026.

Open the full record on USAspending.gov More in Cuyahoga County

Copied from USAspending.gov. Where It Lands is not a government site and is not affiliated with USAspending.gov or the awarding agency.